191 related articles for article (PubMed ID: 18790758)
1. Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.
Yamaguchi K; Cekanova M; McEntee MF; Yoon JH; Fischer SM; Renes IB; Van Seuningen I; Baek SJ
Mol Cancer Ther; 2008 Sep; 7(9):2779-87. PubMed ID: 18790758
[TBL] [Abstract][Full Text] [Related]
2. A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells.
Yamaguchi K; Lee SH; Eling TE; Baek SJ
Mol Cancer Ther; 2006 May; 5(5):1352-61. PubMed ID: 16731769
[TBL] [Abstract][Full Text] [Related]
3. MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Cekanova M; Lee SH; McEntee MF; Baek SJ
Eur J Pharmacol; 2010 Jul; 637(1-3):30-7. PubMed ID: 20385121
[TBL] [Abstract][Full Text] [Related]
4. Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.
Imchen T; Manasse J; Min KW; Baek SJ
Exp Toxicol Pathol; 2013 Sep; 65(6):919-24. PubMed ID: 23369238
[TBL] [Abstract][Full Text] [Related]
5. A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.
Min KW; Zhang X; Imchen T; Baek SJ
Toxicol Appl Pharmacol; 2012 Sep; 263(2):225-32. PubMed ID: 22750490
[TBL] [Abstract][Full Text] [Related]
6. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
Han S; Rivera HN; Roman J
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):350-9. PubMed ID: 15677767
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.
Sun X; Ritzenthaler JD; Zheng Y; Roman J; Han S
Mol Cancer Ther; 2009 Jan; 8(1):110-8. PubMed ID: 19139119
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
Savari S; Chandrashekar NK; Osman J; Douglas D; Bellamkonda K; Jönsson G; Juhas M; Greicius G; Pettersson S; Sjölander A
Carcinogenesis; 2016 May; 37(5):491-9. PubMed ID: 26979937
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Richard CL; Blay J
Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
[TBL] [Abstract][Full Text] [Related]
13. Bile acids induce MUC2 overexpression in human colon carcinoma cells.
Song S; Byrd JC; Koo JS; Bresalier RS
Cancer; 2005 Apr; 103(8):1606-14. PubMed ID: 15754327
[TBL] [Abstract][Full Text] [Related]
14. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
15. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
16. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
17. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1.
Perrais M; Pigny P; Copin MC; Aubert JP; Van Seuningen I
J Biol Chem; 2002 Aug; 277(35):32258-67. PubMed ID: 12077147
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
Baek SJ; Wilson LC; Hsi LC; Eling TE
J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
